Bioaffinity Technologies, Inc. BIAF Stock Forecast
AI-powered price prediction and analysis for Bioaffinity Technologies, Inc. · Total · absolute moveSwitch to Alpha
See BIAF's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.
Price Chart
Key Statistics
About Bioaffinity Technologies, Inc.
Bioaffinity Technologies, Inc. (BIAF) operates within the Industrial Applications and Services sector, specifically in the Services-Commercial Physical & Biological Research industry.
Latest News
Where BIAF sits on the market map
Services-Commercial Physical & Biological Research Peers
Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.
| Company | AI Signal | Market Cap | P/E |
|---|---|---|---|
| BIAF Bioaffinity Technologies, Inc. | ▼ | N/A | – |
| IQV Iqvia Holdings Inc. | ▼ | $43.51B | 32.6x |
| INCY Incyte Corp | ▼ | $21.70B | 17.5x |
| MEDP Medpace Holdings, Inc. | ▶ | $17.02B | 34.6x |
| CRL Charles River Laboratories International, … | ▶ | $14.27B | – |
| ICLR Icon Plc | ▶ | $12.68B | – |
| ABSI Absci Corp | ▲ | $1.56B | – |
| OABI Omniab, Inc. | ▲ | $683M | – |
| NRC Nrc Health | ▲ | $446M | – |
| MXCT Maxcyte, Inc. | ▲ | $100M | – |
| ONMD Onemednet Corp | ▶ | $24M | – |
| VSBC Vitaspring Biomedical Co. Ltd. | ▼ | $7M | – |
| BUDZ Weed, Inc. | ▶ | $3M | – |
| CBIH Cannabis Bioscience International Holdings, … | ▼ | N/A | – |
| FOXO Foxo Technologies Inc. | ▼ | N/A | – |
| ISPC Ispecimen Inc. | ▼ | N/A | – |
FAQ
Is Bioaffinity Technologies, Inc. a good stock to buy?
Our AI analyzes Bioaffinity Technologies, Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.
How accurate are Bioaffinity Technologies, Inc. predictions?
A per-ticker accuracy statistic for BIAF is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are forecasts updated?
Bioaffinity Technologies, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Bioaffinity Technologies, Inc.? View full institutional-grade analysis on Intratio →
AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.